| Rhabdomyolysis secondary to tetanus toxoid administration in a patient following minor laceration M Hursitoglu, MA Cikrikcioglu, E Gundogan, O Ozkan, I Cordan, Y Yigit, ... The Journal of Clinical Pharmacology 51 (1), 110-111, 2011 | 8 | 2011 |
| Impact of COVID-19 on outcomes of patients with hematologic malignancies: A multicenter, retrospective study IH Acar, SI Guner, MA Ak, M Gocer, E Ozturk, F Atalay, G Sincan, ... Mediterranean Journal of Hematology and Infectious Diseases 14 (1), 2022 | 5 | 2022 |
| Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients ZN Özdemir, Y İpek, P Patır, G Ermiş, R Çiftçiler, D Özmen, M Baysal, ... Turkish Journal of Hematology 41 (1), 26, 2024 | 4 | 2024 |
| Castleman disease: a multicenter case series from Turkey E Gunduz, HO Kirkizlar, EG Umit, S Karaman Gulsaran, V Ozkocaman, ... | 3 | 2022 |
| Aile Sağlığı Merkezine Gelen Kadın Hastaların Sezaryen ve Küretaj Hakkındaki Bilgi, Tutum, Davranışları ve Sosyodemografik Özelliklerle İlişkisi GZ ÖZTÜRK, D TOPRAK, M HURŞİTOĞLU, İ Yıldız Journal of Clinical Obstetrics & Gynecology 24 (1), 1-8, 2014 | 3 | 2014 |
| Novel janus-kinase (JAK) inhibitors in myelofibrosis Y İpek, B Kılıç, UB Günay, AE Eskazan Expert Opinion on Investigational Drugs, 2023 | 2 | 2023 |
| Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics AN Kul, Y Ipek Journal of Oncology Pharmacy Practice 29 (7), 1652-1660, 2023 | 2 | 2023 |
| The predictive role of new markers in early diagnosis of acute kidney injury in patients with acute pancreatitis F Karagöz, D Sit, A Kirankaya, YA Karagöz, A Savas, Y Ipek, BE Atay, ... Open Journal of Nephrology 10 (3), 254-263, 2020 | 2 | 2020 |
| Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific … M Baysal, E Aksoy, KH Bedir, D Özmen, P Patır, U Demirci, S Yaman, ... Journal of Thrombosis and Thrombolysis, 1-15, 2024 | | 2024 |
| Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey S Guven, D Özmen, Y Çatma, T Güllü Koca, O Kırkızlar, Ö Şeker, S Ünal, ... Blood 144 (Supplement 1), 6585-6585, 2024 | | 2024 |
| Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group IH Acar, M Aslaner Ak, G Akyol, TU Kars, Y Ipek, A Uysal, F Atalay, ... Medicina 60 (10), 1623, 2024 | | 2024 |
| Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study R Çiftçiler, C Selim, M Cömert, H Zengin, Y İpek, V Gürsoy, E Yıldızhan, ... Journal of Oncology Pharmacy Practice, 10781552241280615, 2024 | | 2024 |
| Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid Leukemia: Effects on Clinical Characteristics and Triglyceride‑to‑High Density Lipoprotein Cholesterol Ratio ET Erkek, AC Isik, Y Ipek, AN Kul Nigerian Journal of Clinical Practice 26 (6), 802-809, 2023 | | 2023 |
| Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients; the Role for PLASMIC and French Scores M Baysal, F Hindilerden, EG Ümit, AM Demir, FK Karadağ, G Saydam, ... Turkish journal of haematology: official journal of Turkish Society of …, 2023 | | 2023 |
| The prevalence and impact of sarcopenia in myeloproliferative neoplasms: Sarcopenia in in myeloproliferative neoplasms Y Ipek, MJK Tuna Journal of Surgery and Medicine 7 (9), 623-627, 2023 | | 2023 |
| CLL-117 Difference in Anxiety Between Oral or Intravenous Treatment in Patients With Chronic Lymphocytic Leukemia Y İpek Clinical Lymphoma Myeloma and Leukemia 23, S321, 2023 | | 2023 |
| 25-hydroxy vitamin D levels in patients with myelofibrosis and potential relationships with disease severity: A case-control study. Y Ipek Journal of Surgery & Medicine (JOSAM) 7 (8), 498-503, 2023 | | 2023 |
| PB2191: A RETROSPECTIVE MULTI-CENTER STUDY ON DIRECT ORAL ANTICOAGULANT USE IN BCR:: ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS M Baysal, P Patir, V Gursoy, R Çiftçiler, U Demirci, D Ozmen, ZN Ozdemir, ... HemaSphere 7 (S3), e22350da, 2023 | | 2023 |
| The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma Y Ipek, N Karademir, O Yilmazer, G Yilmaz Current Oncology 30 (6), 5615-5630, 2023 | | 2023 |
| Factors associated with unresponsiveness to treatment in patients with non-Hodgkin lymphoma: 10 years of experience from a single center I Yildiz, Y Guven Acta Medica Alanya 7 (1), 56-62, 2023 | | 2023 |
